Your browser doesn't support javascript.
loading
Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) "Cis-On" Agonist.
Rodríguez-Soacha, Diego A; Steinmüller, Sophie A M; Isbilir, Ali; Fender, Julia; Deventer, Marie H; Ramírez, Yesid A; Tutov, Anna; Sotriffer, Christoph; Stove, Christophe P; Lorenz, Kristina; Lohse, Martin J; Hislop, James N; Decker, Michael.
Afiliação
  • Rodríguez-Soacha DA; Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany.
  • Steinmüller SAM; Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany.
  • Isbilir A; Institut für Pharmakologie und Toxikologie, Julius-Maximilians-Universität Würzburg, Versbacher Str. 9, D-97078 Würzburg, Germany.
  • Fender J; Receptor Signaling Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
  • Deventer MH; Institut für Pharmakologie und Toxikologie, Julius-Maximilians-Universität Würzburg, Versbacher Str. 9, D-97078 Würzburg, Germany.
  • Ramírez YA; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
  • Tutov A; Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany.
  • Sotriffer C; Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad Icesi, Valle del Cauca, 760031 Cali, Colombia.
  • Stove CP; Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany.
  • Lorenz K; Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany.
  • Lohse MJ; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
  • Hislop JN; Institut für Pharmakologie und Toxikologie, Julius-Maximilians-Universität Würzburg, Versbacher Str. 9, D-97078 Würzburg, Germany.
  • Decker M; Leibniz-Institut für Analytische Wissenschaften─ISAS e.V., Bunsen-Kirchhoff-Str. 11, 44139 Dortmund, Germany.
ACS Chem Neurosci ; 13(16): 2410-2435, 2022 08 17.
Article em En | MEDLINE | ID: mdl-35881914
ABSTRACT
Activation of the human cannabinoid receptor type 1 (hCB1R) with high spatiotemporal control is useful to study processes involved in different pathologies related to nociception, metabolic alterations, and neurological disorders. To synthesize new agonist ligands for hCB1R, we have designed different classes of photoswitchable molecules based on an indole core. The modifications made to the central core have allowed us to understand the molecular characteristics necessary to design an agonist with optimal pharmacological properties. Compound 27a shows high affinity for CB1R (Ki (cis-form) = 0.18 µM), with a marked difference in affinity with respect to its inactive "trans-off" form (CB1R Ki trans/cis ratio = 5.4). The novel compounds were evaluated by radioligand binding studies, receptor internalization, sensor receptor activation (GRABeCB2.0), Western blots for analysis of ERK1/2 activation, NanoBiT ßarr2 recruitment, and calcium mobilization assays, respectively. The data show that the novel agonist 27a is a candidate for studying the optical modulation of cannabinoid receptors (CBRs), serving as a new molecular tool for investigating the involvement of hCB1R in disorders associated with the endocannabinoid system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amidas / Hexaclorobenzeno Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amidas / Hexaclorobenzeno Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2022 Tipo de documento: Article